New-Onset Status Epilepticus in an 11-year-old Patient with Thyroid Autoimmune Dysfunction: A Case Report of Pediatric Hashimoto Encephalopathy
Journal of Pediatric Epilepsy · 01.12.2024 · 13 (04) · 092-095
DOI: 10.1055/s-0044-1788053 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Pediatric Epilepsy, erschienen am 01.12.2024. Verfasst von Aldo F. Costa und 3 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Hashimoto encephalopathy (HE) is a neuropsychiatric syndrome associated with positive thyroid antibodies (Ab). Its pathophysiology is still in debate and pediatric cases are considered rare. We present a case of an 11-year-old girl with new-onset refractory status epilepticus (NORSE) who presented a good initial response to corticosteroids but then required a second line of treatment with mycophenolate. In children presenting with NORSE of suspected autoimmune origin and no identification of autoimmune encephalitis traditional Ab, HE must be considered.
Zitieren
APA
Costa, A. F., Fernández-Ramos, J. A., Cazorla, C., & López-Laso, E. (2024). New-Onset Status Epilepticus in an 11-year-old Patient with Thyroid Autoimmune Dysfunction: A Case Report of Pediatric Hashimoto Encephalopathy. Journal of Pediatric Epilepsy, 13(04), 092-095. https://doi.org/10.1055/s-0044-1788053
Vancouver
Costa AF, Fernández-Ramos JA, Cazorla C, López-Laso E. New-Onset Status Epilepticus in an 11-year-old Patient with Thyroid Autoimmune Dysfunction: A Case Report of Pediatric Hashimoto Encephalopathy. Journal of Pediatric Epilepsy. 2024;13(04):092-095. doi:10.1055/s-0044-1788053
BibTeX
@article{Costa2024,
author = {Costa, Aldo F. and Fernández-Ramos, Joaquín A. and Cazorla, Cristina and López-Laso, Eduardo},
title = {New-Onset Status Epilepticus in an 11-year-old Patient with Thyroid Autoimmune Dysfunction: A Case Report of Pediatric Hashimoto Encephalopathy},
journal = {Journal of Pediatric Epilepsy},
year = {2024},
volume = {13},
number = {04},
pages = {092--095},
doi = {10.1055/s-0044-1788053}
}
EUVIMED